Ovarian follicular dynamics: from basic science to clinical practice (Q40838482)

24 September 2017

1 reference

title

Ovarian follicular dynamics: from basic science to clinical practice (English)

1 reference

24 September 2017

7

1 reference

24 September 2017

Pellicer A

1

1 reference

24 September 2017

Gaitán P

2

1 reference

24 September 2017

Neuspiller F

3

1 reference

24 September 2017

Ardiles G

4

1 reference

24 September 2017

Albert C

5

1 reference

24 September 2017

Remohí J

6

1 reference

24 September 2017

1 August 1998

1 reference

Journal of Reproductive Immunology

24 September 2017

1 reference

24 September 2017

39

1 reference

24 September 2017

1-2

1 reference

24 September 2017

29-61

1 reference

The potential relevance of cytokines to ovarian physiology

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

1 reference

7 January 2021

A quantitative and cytological study of germ cells in human ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

A quantitative morphological investigation of the follicular system in newborn female infants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Growth hormone--a cogonadotropin? Its role in ovulation induction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Effect of aging on the female reproductive system: evidence for a role of uterine senescence in the decline in female fecundity.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Selection criteria for human embryo transfer: a comparison of pyruvate uptake and morphology.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Purification of a candidate gonadotropin surge inhibiting factor from porcine follicular fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Ovarian control of follicle development

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

A mathematical model of follicle dynamics in the human ovary.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Interference with follicle stimulating hormone regulation of human ovarian function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Manipulation of human ovarian function: physiological concepts and clinical consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Morphometric study of the human neonatal ovary.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Fusing the carboxy-terminal peptide of the chorionic gonadotropin (CG) beta-subunit to the common alpha-subunit: retention of O-linked glycosylation and enhanced in vivo bioactivity of chimeric human CG.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Evolution of clinical agents for ovulation induction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

The evolution of new agents for ovulation induction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Growth factors in reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Age does not affect uterine resistance to vascular flow in patients undergoing oocyte donation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Wilms' tumor protein WT1 as an ovarian transcription factor: decreases in expression during follicle development and repression of inhibin-alpha gene promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Inhibin and estradiol responses to ovarian hyperstimulation: effects of age and predictive value for in vitro fertilization outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Effect of age on response to human menopausal gonadotropin stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Inhibin concentrations throughout the menstrual cycles of normal, infertile, and older women compared with those during spontaneous conception cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

No beneficial effects of human growth hormone therapy in normal ovulatory patients with a poor ovarian response to gonadotropins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Another look at co-treatment with growth hormone and human menopausal gonadotrophins in poor ovarian responders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Poor responders to ovarian hyperstimulation may benefit from an attempt at natural-cycle oocyte retrieval

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

The value of increasing the dose of human menopausal gonadotropins in women who initially demonstrate a poor response.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

1 reference

7 January 2021

An accurate, simple method for unbiased determination of primordial follicle number in the primate ovary.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

The basic science of gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Prognostic assessment of female fecundity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo-control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Co-treatment with growth hormone of sub-optimal responders in IVF-ET.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Oestrogens and follicular and oocyte development

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Outcome of in vitro fertilization in women with low response to ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Ovarian response and outcome of in-vitro fertilization in patients treated with gonadotrophin-releasing hormone analogues in different phases of the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Aetiological factors involved in the low response to gonadotrophins in infertile women with normal basal serum follicle stimulating hormone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Effects of aging on the human ovary: the secretion of immunoreactive alpha-inhibin and progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Are clinical and biological IVF parameters correlated with chromosomal disorders in early life: a multicentric study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Specific binding of luteinizing hormone releasing hormone to human luteal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Adjunctive growth hormone during ovarian hyperstimulation increases levels of insulin-like growth factor binding proteins in follicular fluid: a randomized, placebo-controlled, cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Long oestradiol replacement in an oocyte donation programme.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Pregnancy and birth rates after oocyte donation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Evaluation and treatment of low responders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Precursors of alpha-inhibin modulate follicle-stimulating hormone receptor binding and biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Apoptosis as a function of ovarian reserve in women undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Absence of effect of adjuvant growth hormone therapy on follicular responses to exogenous gonadotropins in women: normal and poor responders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Induction of luteolysis by luteinizing hormone-releasing factor (LRF) agonist: sensitivity, reproducibility, and reversibility

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Biosynthesis of a biologically active single peptide chain containing the human common alpha and chorionic gonadotropin beta subunits in tandem

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Ovarian response to combined growth hormone-gonadotropin treatment in patients resistant to induction of superovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Developmental potential of embryos produced by in-vitro fertilization from gonadotrophin-releasing hormone antagonist-treated macaques stimulated with recombinant human follicle stimulating hormone alone or in combination with luteinizing hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Is subclinical ovarian failure an autoimmune disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Inhibin and beta type transforming growth factor (TGF beta) have opposite modulating effects on the follicle stimulating hormone (FSH)-induced aromatase activity of cultured rat granulosa cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

Gonadotropin-Binding Sites in the Rhesus Monkey Ovary: Role of the Vasculature in the Selective Distribution of Human Chorionic Gonadotropin to the Preovulatory Follicle*

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0378%2898%2900012-6

7 January 2021

10.1016/S0165-0378(98)00012-6

Identifiers

DOI

1 reference

24 September 2017

1 reference